NM_001142800.2:c.863-23_863-22dupTT
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001142800.2(EYS):c.863-23_863-22dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 1,469,002 control chromosomes in the GnomAD database, including 20,765 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.23 ( 4035 hom., cov: 0)
Exomes 𝑓: 0.21 ( 16730 hom. )
Consequence
EYS
NM_001142800.2 intron
NM_001142800.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.391
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 6-65405388-G-GAA is Benign according to our data. Variant chr6-65405388-G-GAA is described in ClinVar as [Benign]. Clinvar id is 1225094.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.863-23_863-22dupTT | intron_variant | Intron 5 of 42 | ENST00000503581.6 | NP_001136272.1 | ||
EYS | NM_001292009.2 | c.863-23_863-22dupTT | intron_variant | Intron 5 of 43 | NP_001278938.1 | |||
EYS | NM_001142801.2 | c.863-23_863-22dupTT | intron_variant | Intron 5 of 11 | NP_001136273.1 | |||
EYS | NM_198283.2 | c.863-23_863-22dupTT | intron_variant | Intron 4 of 9 | NP_938024.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.863-22_863-21insTT | intron_variant | Intron 5 of 42 | 5 | NM_001142800.2 | ENSP00000424243.1 | |||
EYS | ENST00000370621.7 | c.863-22_863-21insTT | intron_variant | Intron 5 of 43 | 1 | ENSP00000359655.3 | ||||
EYS | ENST00000393380.6 | c.863-22_863-21insTT | intron_variant | Intron 5 of 11 | 1 | ENSP00000377042.2 | ||||
EYS | ENST00000342421.9 | c.863-22_863-21insTT | intron_variant | Intron 3 of 8 | 1 | ENSP00000341818.5 |
Frequencies
GnomAD3 genomes AF: 0.231 AC: 34198AN: 148036Hom.: 4024 Cov.: 0
GnomAD3 genomes
AF:
AC:
34198
AN:
148036
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.234 AC: 47327AN: 202572Hom.: 3128 AF XY: 0.234 AC XY: 25940AN XY: 110630
GnomAD3 exomes
AF:
AC:
47327
AN:
202572
Hom.:
AF XY:
AC XY:
25940
AN XY:
110630
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.207 AC: 273176AN: 1320876Hom.: 16730 Cov.: 25 AF XY: 0.209 AC XY: 138299AN XY: 660614
GnomAD4 exome
AF:
AC:
273176
AN:
1320876
Hom.:
Cov.:
25
AF XY:
AC XY:
138299
AN XY:
660614
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.231 AC: 34244AN: 148126Hom.: 4035 Cov.: 0 AF XY: 0.237 AC XY: 17066AN XY: 72104
GnomAD4 genome
AF:
AC:
34244
AN:
148126
Hom.:
Cov.:
0
AF XY:
AC XY:
17066
AN XY:
72104
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 11, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Retinitis pigmentosa 25 Benign:1
Sep 27, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at